Ekso Bionics Holdings, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

Annual report [Section 13 and 15(d), not S-K Item 405]

Note 14 - Income Taxes (Tables)

Note 14 - Income Taxes (Tables)

12 Months Ended

Dec. 31, 2025

Notes Tables

Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]

		*Years Ended December 31,*
		*2025*				*2024*
Domestic		$	(11,400	)		$	(11,576	)
Foreign			(295	)			246
Loss before income taxes		$	(11,695	)		$	(11,330	)

Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]

		*Year Ended December 31,*
		*2025*
U.S. federal statutory income tax rate		$	(2,456	)			21.0	%
State tax, net of federal tax effect			—				—
Foreign tax effects:
Changes in valuation allowances (Germany)			553				(4.7	)
Changes in valuation allowances (Other Foreign Jurisdictions)			(22	)			0.2
Prior year true-ups (Germany)			(293	)			2.5
Other			(47	)			0.4
Change in valuation allowance			2,194				(18.8	)
Imputed interest income			154				(1.3	)
Unrealized gain			(394	)			3.4
Stock-based compensation			427				(3.7	)
Prior year true-ups			(157	)			1.3
Other			41				(0.3	)
Total tax expense (benefit)		$	—				—	%

		Year Ended December 31,
		2024
Federal tax at statutory rate			21.0	%
State tax, net of federal tax effect			—
Research and development credit			(0.1	)
Change in valuation allowance			(13.5	)
Unrealized gain on warrant			0.7
Stock-based compensation			(4.7	)
Other			(2.8	)
Foreign			(0.6	)
Total tax expense (benefit)			—	%

Schedule of Deferred Tax Assets and Liabilities [Table Text Block]

		*December 31,*
		*2025*				*2024*
Deferred tax assets:
Depreciation and other		$	297			$	119
Net operating loss carryforwards			57,646				54,001
Research and development tax credits			2,210				2,210
Accruals and reserves			245				235
Capitalized research and development costs			1,360				1,817
Deferred revenue			431				400
Stock compensation expense			648				1,028
Lease assets			82				154
Other			41				48

Deferred tax liabilities:
Lease liabilities			(70	)			(133	)
Prepaid expenses			(45	)			(54	)
Less: Valuation allowance			(62,845	)			(59,825	)
Net deferred tax asset (liability)		$	—			$	—

Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]

		*Years Ended December 31,*
		*2025*				*2024*
Beginning balances as of January 1, 2025 and 2024		$	1,836			$	1,894
(Decrease) of unrecognized tax benefits taken in prior years			(43	)			(58	)
Ending balances as of December 31, 2025 and 2024		$	1,793			$	1,836